Risedronate Sodium in Post Menopausal Osteoporosis

Summary

The primary objective is to compare subject satisfaction of once a week dosing of 35 mg Actonel to once daily dosing of 5 mg Actonel in postmenopausal osteoporotic women. The secondary objectives are to measure compliance (50 % drug taken), and persistence, \[and urinary NTx (N-telopeptides) (optional)\].

Timeline

Start

2004-01

Primary completion

—

Completion

—

Drugs

Indications